Enabling Clinical Trial Innovation Through AI Regulation at FDA
As the FDA stakes its claim as the primary regulator of AI in healthcare, it must navigate the delicate balance between fostering innovation and ensuring safety and responsibility.
ACA repeal, CHIP renewal could top Trump’s healthcare agenda
Here are some of the major health issues that are certain to come up in 2017.
presented by
The Healthcare Payments Industry Faces a Perception Challenge
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
FDA raises its PDUFA and MDUFA user fees
As it does every year, the FDA has changed its PDUFA and MDUFA fees - and in most cases, it increases.